levodopa-carbidopa intestinal gel
Showing 1 - 25 of 5,868
Advanced Parkinson's Disease Trial (Levodopa-Carbidopa Intestinal Gel, Percutaneous Endoscopic Gastrostomy with Jejunal
Completed
- Advanced Parkinson's Disease
- Levodopa-Carbidopa Intestinal Gel
- +2 more
- (no location specified)
Jul 14, 2021
Advanced Parkinson's Disease Trial in Worldwide (Optimized Medical Treatment, Levodopa-Carbidopa Intestinal Gel, Nasojejunal
Completed
- Advanced Parkinson's Disease
- Optimized Medical Treatment
- +3 more
-
Fountain Valley, California
- +37 more
Nov 19, 2022
Assess Participant/Caregiver/Investigator Satisfaction of
Completed
- Parkinson's Disease
-
Herston, Queensland, Australia
- +12 more
Jan 31, 2023
Advanced Parkinson's Disease Trial in Worldwide (Levodopa-carbidopa intestinal gel, CADD-Legacy® 1400 ambulatory infusion pump)
Completed
- Advanced Parkinson's Disease
- Levodopa-carbidopa intestinal gel
- CADD-Legacy® 1400 ambulatory infusion pump
-
Birmingham, Alabama
- +60 more
Nov 3, 2021
Parkinson's Disease (PD) Trial in Worldwide (Optimized antiparkinsonian treatment, Levodopa-Carbidopa Intestinal Gel (LCIG),
Completed
- Parkinson's Disease (PD)
- Optimized antiparkinsonian treatment
- +4 more
-
Port Charlotte, Florida
- +27 more
Aug 10, 2020
Parkinson's Disease Trial in Amsterdam (Continuous intrajejunal infusion of levodopa-carbidopa, deep brain stimulation)
Active, not recruiting
- Parkinson's Disease
- Continuous intrajejunal infusion of levodopa-carbidopa
- deep brain stimulation
-
Amsterdam, Noord Holland, NetherlandsAcademic Medical Center
Apr 20, 2022
Small Intestine and Blood Fingerprint Study in Parkinson's
Not yet recruiting
- Parkinson Disease
- Fluid biopsy capsule
- Levodopa-Carbidopa Immediate Release
-
Calgary, Alberta, CanadaUniversity of Calgary
Aug 15, 2023
Mono- and cOmbination Therapy With Levodopa-carbidopa inteStinal
Completed
- Parkinson's Disease (PD)
-
Hermagor-Pressegger See, Kaernten, Austria
- +29 more
Dec 17, 2019
DESENSITIZE-PD: Intestinal Levodopa + Entacapone Therapy to
Not yet recruiting
- Parkinson Disease
- (no location specified)
Oct 14, 2022
Parkinson Disease, Treatment Adherence Trial in Ankara (Levodopa)
Enrolling by invitation
- Parkinson Disease
- Treatment Adherence
-
Ankara, TurkeyAnkara Atatürk Sanatorium Training and Research Hospital
Oct 30, 2023
Long-term Health Outcomes of Canadian DUODOPA-treated Patients
Completed
- Parkinson Disease (PD)
-
Calgary, Alberta, Canada
- +12 more
Jun 23, 2021
Quality of Life in LCIG Patients and LCIG Eligible Patients
Completed
- Parkinson's Disease (PD)
-
Aachen, Nordrhein-Westfalen, Germany
- +26 more
Dec 7, 2020
Levodopa-carbidopa Intestinal Gel Infusion
Unknown status
- Parkinson Disease
-
Barcelona, SpainHospital Universitari Vall d'Hebron
Jul 18, 2018
Idiopathic Parkinson Disease Trial in Minneapolis (levodopa/carbidopa oral formulation A, levodopa/carbidopa oral formulation B,
Not yet recruiting
- Idiopathic Parkinson Disease
- levodopa/carbidopa oral formulation A
- +2 more
-
Minneapolis, MinnesotaUniversity of Minnesota
Jul 20, 2022
Long-Term Effectiveness of Duodopa/Duopa in Advanced Parkinson's
Completed
- Advanced Parkinson's Disease
-
Birmingham, Alabama
- +53 more
Dec 7, 2021
Parkinson Disease Trial in Rome (Standard LD/CD, Semi continuous intra-oral administration of LD/CD)
Completed
- Parkinson Disease
- Standard LD/CD
- Semi continuous intra-oral administration of LD/CD
-
Rome, ItalyIrccs San Raffaele Pisana
Oct 17, 2022
Parkinson Disease Trial in Ahmedabad (WD-1603 Carbidopa-Levodopa Extended-Release Tablets)
Recruiting
- Parkinson Disease
- WD-1603 Carbidopa-Levodopa Extended-Release Tablets
-
Ahmedabad, Gujarat, IndiaLambda Therapeutic Research Ltd.
Nov 10, 2021
Healthy Trial (Test (T) Entacapone,Levodopa and Carbidopa Tablets (II), Reference (R) Entacapone,Levodopa and Carbidopa Tablets
Not yet recruiting
- Healthy
- Test (T) Entacapone,Levodopa and Carbidopa Tablets (II)
- Reference (R) Entacapone,Levodopa and Carbidopa Tablets (II)
- (no location specified)
Jul 26, 2023
Parkinson Disease Trial in Shanghai (WD-1603 Carbidopa-Levodopa Extended-Release Tablets, Placebo)
Recruiting
- Parkinson Disease
- WD-1603 Carbidopa-Levodopa Extended-Release Tablets
- Placebo
-
Shanghai, Shanghai, ChinaShanghai Huashan Hospital
Oct 28, 2021
Parkinson Disease Trial in Gothenburg (Infudopa i.v., Infudopa s.c., LCIG (Duodopa))
Completed
- Parkinson Disease
- Infudopa i.v.
- +2 more
-
Gothenburg, SwedenSahlgrenska Universtiy Hospital, Dep of Neurology
Nov 4, 2020
Spinal Cord Injuries Trial in Bronx (CPH + hand training, CD-LD + hand training, ATX + hand training)
Recruiting
- Spinal Cord Injuries
- CPH + hand training
- +3 more
-
Bronx, New YorkJames J. Peters Veterans Affairs Medical Center
Jan 23, 2023